A new in vitro checkerboard-parasite reduction ratio interaction assay for early de-risk of clinical development of antimalarial combinations
C. Demarta-Gatsi, S. Wicha, A. Walz, M. H. Cherkaoui-Rbati, C. Gumpp, N. Gobeau, J. J. Möhrle, M. Rottmann
This paper introduces an in vitro assay to predict antimalarial drug combination efficacy, showing it can accurately predict clinical trial outcomes and provide detailed pharmacodynamic insights.
bioRxiv · Apr 19, 2022 · PreprintMicrobiology